Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Capital Leases: 2011-2013

Historic Capital Leases for SELLAS Life Sciences Group (SLS) over the last 3 years, with Sep 2013 value amounting to $30,000.

  • SELLAS Life Sciences Group's Capital Leases fell 41.18% to $30,000 in Q3 2013 from the same period last year, while for Sep 2013 it was $30,000, marking a year-over-year decrease of 41.18%. This contributed to the annual value of $51,000 for FY2012, which is 59.38% up from last year.
  • According to the latest figures from Q3 2013, SELLAS Life Sciences Group's Capital Leases is $30,000, which was down 11.76% from $34,000 recorded in Q2 2013.
  • In the past 5 years, SELLAS Life Sciences Group's Capital Leases registered a high of $51,000 during Q3 2012, and its lowest value of $10,000 during Q2 2011.
  • For the 3-year period, SELLAS Life Sciences Group's Capital Leases averaged around $34,333, with its median value being $34,000 (2013).
  • In the last 5 years, SELLAS Life Sciences Group's Capital Leases skyrocketed by 264.29% in 2012 and then slumped by 41.18% in 2013.
  • SELLAS Life Sciences Group's Capital Leases (Quarterly) stood at $32,000 in 2011, then skyrocketed by 59.38% to $51,000 in 2012, then plummeted by 41.18% to $30,000 in 2013.
  • Its Capital Leases was $30,000 in Q3 2013, compared to $34,000 in Q2 2013 and $51,000 in Q1 2013.